Medical Conditions Affecting Women’s Mental Health

  • Sarah Rückl
  • Tiago Couto
  • Juliana Parada
  • Carlos Eduardo RosaEmail author


Patients with severe mental illness (SMI) have 13 to 30 years shortened life expectancy when compared to the general population, and 60% of this excess mortality is caused by physical illnesses. Behavioral and social risk factors, as well as a poor quality of physical healthcare offer, contribute to higher rates of medical illness in this population. Sex and gender are individual risk factors, and both account for the expression of disorders. Sex is biological and determines reproductive function, sexual hormones, and gene expression. On the other hand, gender is associated with behavior and life experience. When considering women’s health, some medical conditions, as, for example, thyroid disorders, are more prevalent and can affect women’s mental health. This chapter aims to describe the relationship between the main clinical disorders affecting females and their mental health.


Gender medicine Sex difference Depression Anxiety Medical condition Liaison psychiatric Women’s mental health 


  1. 1.
    Huth EJ, Murray TJ, Murray TJ. In: Edward Huthm EJ, Jock MT, editors. Medicine in quotations: views of health and disease through the ages. Philadelphia: American College of Physicians; 2000. 524 p.Google Scholar
  2. 2.
    Kaminetzky H. A drug on the market. Obstet Gynecol [Internet]. 1963 [cited 2017 Aug 17];21:512–3. Available from:
  3. 3.
    Sacks O. The man who mistook his wife for a hat: and other clinical tales. Frist Touch. New York: Touchstone; 1998. 256 p.Google Scholar
  4. 4.
    Pereira VH, Morgado P, Gonçalves M, Costa L, Sousa N, Cerqueira JJ. An objective structured clinical exam to assess semiology skills of medical students. Acta Med Port [Internet]. 2016 [cited 2017 Jun 11];29(12):819. Available from:
  5. 5.
    Patten S. The physical examination in psychiatry. Jefferson J Psychiatry. 1998;6(2):4.Google Scholar
  6. 6.
    De Hert M, Cohen D, Bobes J, Cetkovich-Bakmas M, Leucht S, Ndetei DM, et al. Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level. World Psychiatry. 2011;10(2):138–51.CrossRefGoogle Scholar
  7. 7.
    Janssen EM, McGinty EE, Azrin ST, Juliano-Bult D, Daumit GL. Review of the evidence: prevalence of medical conditions in the United States population with serious mental illness. Gen Hosp Psychiatry. 2015;37(3):199–222.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Liu NH, Daumit GL, Dua T, Aquila R, Charlson F, Cuijpers P, et al. Forum – the need for a comprehensive approach to excess mortality in persons with severe mental disorders (in collaboration with the World Health Organization). Excess mortality in persons with severe mental disorders: a multilevel intervention framework and priorities for clinical practice, policy and research agendas. World Psychiatry. 2017;16(February):30–40.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Regitz-Zagrosek V. Sex and gender differences in health. EMBO Rep [Internet]. 2012;13(7):596–603. Available from:
  10. 10.
    Oertelt-Prigione S, Regitz-Zagrosek V. Sex and gender aspects in clinical medicine. London: Springer; 2012.CrossRefGoogle Scholar
  11. 11.
    Murphy MO, Cohn DM, Loria AS. Developmental origins of cardiovascular disease: Impact of early life stress in humans and rodents. Neurosci Biobehav Rev [Internet]. 2017 [cited 2017 Aug 21];74(Pt B):453–65. Available from:
  12. 12.
    Antman EM, Loscalzo J. Ischemic heart disease. In: Kasper D, Fauci A, Hauser S, Longo D, Jameson J, Loscalzo J, editors. Harrison’s principles of internal medicine [Internet]. 19 th ed. New York: McGraw-Hill Education; 2014. p. 1578–92. Available from: Accessed agosto 22, 2017.
  13. 13.
    Kones R. Molecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes. Vasc Health Risk Manag. 2013;9:617.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Kones R. Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey. Drug Des Devel Ther. 2011;5:325.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Anand SS, Islam S, Rosengren A, Franzosi MG, Steyn K, Yusufali AH, et al. Risk factors for myocardial infarction in women and men: insights from the INTERHEART study. Eur Heart J. 2008;29(7):932–40.CrossRefGoogle Scholar
  16. 16.
    Setoguchi S, Solomon DH, Levin R, Winkelmayer WC. Gender differences in the management and prognosis of myocardial infarction among patients ≥65 years of age. Am J Cardiol [Internet]. 2008;101:1531–6. Available from:
  17. 17.
    Regitz-Zagrosek V, Seeland U. Sex and gender differences in clinical medicine. Handb Exp Pharmacol. 2012;214:211–36.Google Scholar
  18. 18.
    Graham G, Xiao Y-YK, Taylor T, Boehm A. Analyzing cardiovascular treatment guidelines application to women and minority populations. Sage Open Med. 2017;5:205031211772152.CrossRefGoogle Scholar
  19. 19.
    Dreyer RP, Dharmarajan K, Kennedy KF, Jones PG, Vaccarino V, Murugiah K, et al. Sex differences in 1-year all-cause rehospitalization in patients after acute myocardial infarction: a prospective observational study. Circulation. 2017;135(6):521–31.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Rosenman RH, Chesney MA. The relationship of type A behavior pattern to coronary heart disease. Act Nerv Super (Praha). 1980;22(1):1–45.Google Scholar
  21. 21.
    Haynes SG, Feinleib M, Kannel WB. The relationship of psychosocial factors to coronary heart disease in the Framingham Study. III. Eight-year incidence of coronary heart disease. Am J Epidemiol. 1980;111(1):37–58.CrossRefGoogle Scholar
  22. 22.
    Steca P, D’Addario M, Magrin ME, Miglioretti M, Monzani D, Pancani L, et al. A Type A and Type D combined personality typology in essential hypertension and acute coronary syndrome patients: associations with demographic, psychological, clinical, and lifestyle indicators. PLoS One. 2016;11(9):e0161840.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Denollet J. DS14: standard assessment of negative affectivity, social inhibition, and Type D personality. Psychosom Med. 2005;67(1):89–97.CrossRefGoogle Scholar
  24. 24.
    Al-Ruzzeh S, Athanasiou T, Mangoush O, Wray J, Modine T, George S, et al. Predictors of poor mid-term health related quality of life after primary isolated coronary artery bypass grafting surgery. Heart. 2005;91(12):1557–62.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Chen C-Y, Wang C-L. Psychiatric comorbidity and psychosocial factors matter in heart failure. Acta Cardiol Sin. 2016;32(1):62–4.PubMedPubMedCentralGoogle Scholar
  26. 26.
    Haukkala A, Konttinen H, Laatikainen T, Kawachi I, Uutela A. Hostility, anger control, and anger expression as predictors of cardiovascular disease. Psychosom Med. 2010;72(6):556–62.CrossRefGoogle Scholar
  27. 27.
    Strike PC, Steptoe A. Psychosocial factors in the development of coronary artery disease. Prog Cardiovasc Dis. 2004;46(4):337–47.CrossRefGoogle Scholar
  28. 28.
    Strike PC, Steptoe A. Behavioral and emotional triggers of acute coronary syndromes: a systematic review and critique. Psychosom Med. 2005;67(2):179–86.CrossRefGoogle Scholar
  29. 29.
    Steptoe A, Brydon L. Emotional triggering of cardiac events. Neurosci Biobehav Rev. 2009;33(2):63–70.CrossRefGoogle Scholar
  30. 30.
    Rosengren A, Hawken S, Ôunpuu S, Sliwa K, Zubaid M, Almahmeed WA, et al. Association of psychosocial risk factors with risk of acute myocardial infarction in 11 119 cases and 13 648 controls from 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364(9438):953–62.CrossRefGoogle Scholar
  31. 31.
    Rozanski A, Blumenthal JA, Davidson KW, Saab PG, Kubzansky L. The epidemiology, pathophysiology, and management of psychosocial risk factors in cardiac practice. J Am Coll Cardiol. 2005;45(5):637–51.CrossRefGoogle Scholar
  32. 32.
    Gustad LT, Laugsand LE, Janszky I, Dalen H, Bjerkeset O. Symptoms of anxiety and depression and risk of acute myocardial infarction: the HUNT 2 study. Eur Heart J. 2014;35(21):1394–403.CrossRefGoogle Scholar
  33. 33.
    Rugulies R. Depression as a predictor for coronary heart disease: a review and meta-analysis. Am J Prev Med. 2002;23(1):51–61.CrossRefGoogle Scholar
  34. 34.
    Adams ML, Grandpre J. Dose-response gradients between a composite measure of six risk factors and cognitive decline and cardiovascular disease. Prev Med (Baltim). 2016;91:329–34.CrossRefGoogle Scholar
  35. 35.
    Almas A, Forsell Y, Iqbal R, Janszky I, Moller J, Bai J. Severity of depression, anxious distress and the risk of cardiovascular disease in a swedish population-based cohort. Hashimoto K, editor. PLoS One. 2015;10(10):e0140742.CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Russ TC, Stamatakis E, Hamer M, Starr JM, Kivimäki M, Batty GD. Association between psychological distress and mortality: individual participant pooled analysis of 10 prospective cohort studies. BMJ. 2012;345:e4933.CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Clark A, Seidler A, Miller M. Inverse association between sense of humor and coronary heart disease. Int J Cardiol. 2001;80(1):87–8.CrossRefGoogle Scholar
  38. 38.
    Lambiase MJ, Kubzansky LD, Thurston RC. Positive psychological health and stroke risk: the benefits of emotional vitality. Health Psychol. 2015;34(10):1043–6.CrossRefGoogle Scholar
  39. 39.
    Fraguas RJ, Andrei AM, Andrade MG, Vicente C, Wajngarten M. Liaison in cardiology. In: Miguel EC, Gentil V, Gattaz W, editors. In: Psychiatric clinic the vision of the department and the Institute of Psychiatry of HCFMUSP. Textbook in Portuguese. 1a ed. Barueri: Manole; 2011. p. 1626–45.Google Scholar
  40. 40.
    Larson SL, Owens PL, Ford D, Eaton W. Depressive disorder, dysthymia, and risk of stroke: thirteen-year follow-up from the Baltimore epidemiologic catchment area study. Stroke. 2001;32(9):1979–83.CrossRefGoogle Scholar
  41. 41.
    Bankier B, Januzzi JL, Littman AB. The high prevalence of multiple psychiatric disorders in stable outpatients with coronary heart disease. Psychosom Med. 2004;66(5):645–50.CrossRefGoogle Scholar
  42. 42.
    Lane D, Carroll D, Ring C, Beevers DG, Lip GYH. The prevalence and persistence of depression and anxiety following myocardial infarction. Br J Health Psychol. 2002;7(1):11–21.CrossRefGoogle Scholar
  43. 43.
    Larsen KK, Vestergaard M, Søndergaard J, Christensen B. Screening for depression in patients with myocardial infarction by general practitioners. Eur J Prev Cardiol. 2013;20(5):800–6.CrossRefGoogle Scholar
  44. 44.
    Jani BD, Cavanagh J, Barry SJ, Der G, Sattar N, Mair FS. Revisiting the J shaped curve, exploring the association between cardiovascular risk factors and concurrent depressive symptoms in patients with cardiometabolic disease: findings from a large cross-sectional study. BMC Cardiovasc Disord. 2014;14(1):139.CrossRefPubMedPubMedCentralGoogle Scholar
  45. 45.
    Mittag O, Kampling H, Farin E, Tully PJ. Trajectories of depressive symptoms after a major cardiac event. Health Psychol Open. 2016;3(1):205510291562487.CrossRefGoogle Scholar
  46. 46.
    Schrader G, Cheok F, Hordacre A-L, Marker J. Predictors of depression 12 months after cardiac hospitalization: the identifying depression as a comorbid condition study. Aust N Z J Psychiatry. 2006;40(11–12):1025–30.PubMedGoogle Scholar
  47. 47.
    Lespérance F, Frasure-Smith N, Talajic M, Bourassa MG. Five-year risk of cardiac mortality in relation to initial severity and one-year changes in depression symptoms after myocardial infarction. Circulation. 2002;105(9):1049–53.CrossRefGoogle Scholar
  48. 48.
    Razmara A, Valle N, Markovic D, Sanossian N, Ovbiagele B, Dutta T, et al. Depression is associated with a higher risk of death among stroke survivors. J Stroke Cerebrovasc Dis. 2017;26:2870–9.CrossRefGoogle Scholar
  49. 49.
    Lichtman JH, Bigger JT, Blumenthal JA, Frasure-Smith N, Kaufmann PG, Lesperance F, et al. Depression and coronary heart disease: recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Psychiatric Association. Circulation. 2008;118(17):1768–75.CrossRefGoogle Scholar
  50. 50.
    Lichtman JH, Bigger JT, Blumenthal JA, Frasure-Smith N, Kaufmann PG, Lespérance F, et al. AHA science advisory. Prog Cardiovasc Nurs. 2009;24(1):19–26.CrossRefGoogle Scholar
  51. 51.
    Whang W, Burg MM, Carney RM, Freedland KE, Bigger JT, Catellier D, et al. Design and baseline data from the vanguard of the Comparison of Depression Interventions after Acute Coronary Syndrome (CODIACS) randomized controlled trial. Contemp Clin Trials. 2012;33(5):1003–10.CrossRefPubMedPubMedCentralGoogle Scholar
  52. 52.
    Richards SH, Dickens C, Anderson R, Richards DA, Taylor RS, Ukoumunne OC, et al. Assessing the effectiveness of enhanced psychological care for patients with depressive symptoms attending cardiac rehabilitation compared with treatment as usual (CADENCE): study protocol for a pilot cluster randomised controlled trial. Trials. 2016;17(1):59.CrossRefPubMedPubMedCentralGoogle Scholar
  53. 53.
    Taylor V, MacQueen G. Associations between bipolar disorder and metabolic syndrome: a review. J Clin Psychiatry [Internet]. 2006 [cited 2017 Aug 23];67(7):1034–41. Available from:
  54. 54.
    Calkin CV, Gardner DM, Ransom T, Alda M. The relationship between bipolar disorder and type 2 diabetes: More than just co-morbid disorders. Ann Med [Internet]. 2013 [cited 2017 Aug 23];45(2):171–81. Available from:
  55. 55.
    Weiner M, Warren L, Fiedorowicz JG. Cardiovascular morbidity and mortality in bipolar disorder. Ann Clin Psychiatry [Internet]. 2011 [cited 2017 Aug 23];23(1):40–7. Available from:
  56. 56.
    Murray DP, Weiner M, Prabhakar M, Fiedorowicz JG. Mania and mortality: why the excess cardiovascular risk in bipolar disorder? Curr Psychiatry Rep [Internet]. 2009 [cited 2017 Aug 23];11(6):475–80. Available from:
  57. 57.
    Allgulander C. Anxiety as a risk factor in cardiovascular disease. Curr Opin Psychiatry. 2016;29(1):13–7.CrossRefGoogle Scholar
  58. 58.
    Celano CM, Daunis DJ, Lokko HN, Campbell KA, Huffman JC. Anxiety disorders and cardiovascular disease. Curr Psychiatry Rep. 2016;18:101.CrossRefPubMedPubMedCentralGoogle Scholar
  59. 59.
    Celano CM, Millstein RA, Bedoya CA, Healy BC, Roest AM, Huffman JC. Association between anxiety and mortality in patients with coronary artery disease: a meta-analysis. Am Heart J. 2015;170(6):1105–15.CrossRefPubMedPubMedCentralGoogle Scholar
  60. 60.
    Lambiase MJ, Kubzansky LD, Thurston RC. Prospective study of anxiety and incident stroke. Stroke. 2014;45(2):438–43.CrossRefGoogle Scholar
  61. 61.
    Frasure-Smith N, Lespérance F. Depression and anxiety as predictors of 2-year cardiac events in patients with stable coronary artery disease. Arch Gen Psychiatry [Internet]. 2008 [cited 2017 Aug 19];65(1):62. Available from:
  62. 62.
    Shapiro PA, Critchfield AR. Cardiovascular disorders. In: Sadock BJ, Sadock VA, Ruiz P, editors. Kaplan & Sadock’s comprehensive textbook of psychiatry two volumes. 10th ed. Philadelphia: Wolters Kluwer; 2017. p. 2186–200.Google Scholar
  63. 63.
    Edmondson D, von Känel R. Post-traumatic stress disorder and cardiovascular disease. Lancet Psychiatry [Internet]. 2017 [cited 2017 Aug 23];4(4):320–9. Available from:
  64. 64.
    Ginzburg K, Solomon Z, Dekel R, Bleich A. Longitudinal study of acute stress disorder, posttraumatic stress disorder and dissociation following myocardial infarction. J Nerv Ment Dis [Internet]. 2006 [cited 2017 Aug 19];194(12):945–50. Available from:
  65. 65.
    Tulloch H, Greenman PS, Tassé V. Post-traumatic stress disorder among cardiac patients: prevalence, risk factors, and considerations for assessment and treatment. Behav Sci (Basel, Switzerland) [Internet]. 2014 [cited 2017 Aug 16];5(1):27–40. Available from:
  66. 66.
    Albert CM, Chae CU, Rexrode KM, Manson JE, Kawachi I. Phobic anxiety and risk of coronary heart disease and sudden cardiac death among women. Circulation [Internet]. 2005 [cited 2017 Aug 23];111(4):480–7. Available from:
  67. 67.
    Bashore TM, Granger CB, Jackson KP, Patel MR. Heart disease. In: Papadakis MA, McPhee S, Rabow M, editors. Current medical diagnosis & treatment 2017. 56th ed. New York: McGraw-Hill Education; 2017.Google Scholar
  68. 68.
    Mann D, Chakinala M. Heart failure: pathophysiology and diagnosis. In: Kasper D, Fauci A, Hauser S, Longo D, Jameson J, Loscalzo J, editors. Harrison’s principles of internal medicine. 19th ed. New York: McGraw-Hill; 2014.Google Scholar
  69. 69.
    Graven LJ, Grant JS, Vance DE, Pryor ER, Grubbs L, Karioth S. Factors associated with depressive symptoms in patients with heart failure. Home Healthc Nurse [Internet]. 2014 [cited 2017 Aug 20];32(9):550–5. Available from:
  70. 70.
    Gottlieb SS, Khatta M, Friedmann E, Einbinder L, Katzen S, Baker B, et al. The influence of age, gender, and race on the prevalence of depression in heart failure patients. J Am Coll Cardiol [Internet]. 2004 [cited 2017 Aug 20];43(9):1542–9. Available from:
  71. 71.
    Gathright EC, Goldstein CM, Josephson RA, Hughes JW. Depression increases the risk of mortality in patients with heart failure: a meta-analysis. J Psychosom Res [Internet]. 2017 [cited 2017 Aug 20];94:82–9. Available from:
  72. 72.
    Aggelopoulou Z, Fotos NV, Chatziefstratiou AA, Giakoumidakis K, Elefsiniotis I, Brokalaki H. The level of anxiety, depression and quality of life among patients with heart failure in Greece. Appl Nurs Res [Internet]. 2017 [cited 2017 Aug 20];34:52–6. Available from:
  73. 73.
    Heo S, Lennie TA, Moser DK, Kennedy RL. Types of social support and their relationships to physical and depressive symptoms and health-related quality of life in patients with heart failure. Heart Lung J Acute Crit Care [Internet]. 2014 [cited 2017 Aug 20];43(4):299–305. Available from:
  74. 74.
    Friedmann E, Son H, Thomas SA, Chapa DW, Lee HJ. Poor social support is associated with increases in depression but not anxiety over 2 years in heart failure outpatients. J Cardiovasc Nurs [Internet]. 2014 [cited 2017 Aug 20];29(1):20–8. Available from:
  75. 75.
    Parissis JT, Nikolaou M, Farmakis D, Bistola V, Paraskevaidis IA, Adamopoulos S, et al. Clinical and prognostic implications of self-rating depression scales and plasma B-type natriuretic peptide in hospitalised patients with chronic heart failure. Heart [Internet]. 2008 [cited 2017 Aug 20];94(5):585–9. Available from:
  76. 76.
    Andrei AM, Fraguas R, Telles RMS, Alves TCTF, Strunz CMC, Nussbacher A, et al. Major depressive disorder and inflammatory markers in elderly patients with heart failure. Psychosomatics [Internet]. 2007 [cited 2017 Aug 20];48(4):319–24. Available from:
  77. 77.
    Alves TCTF, Rays J, Fráguas R, Wajngarten M, Telles RMS, Duran FLDS, et al. Association between major depressive symptoms in heart failure and impaired regional cerebral blood flow in the medial temporal region: a study using 99m Tc-HMPAO single photon emission computerized tomography (SPECT). Psychol Med [Internet]. 2006 [cited 2017 Aug 21];36(5):597–608. Available from:
  78. 78.
    Alves TCTF, Rays J, Fráguas R, Wajngarten M, Meneghetti JC, Prando S, et al. Localized cerebral blood flow reductions in patients with heart failure: a study using 99mTc-HMPAO SPECT. J Neuroimaging [Internet]. 2005 [cited 2017 Aug 21];15(2):150–6. Available from:
  79. 79.
    Almeida JRC, Alves TCTF, Wajngarten M, Rays J, Castro CC, Cordeiro Q, et al. Late-life depression, heart failure and frontal white matter hyperintensity: a structural magnetic resonance imaging study. Braz J Med Biol Res [Internet]. 2005 [cited 2017 Aug 21];38(3):431–6. Available from:
  80. 80.
    Alosco ML, Spitznagel MB, Raz N, Cohen R, Sweet LH, Garcia S, et al. The interactive effects of cerebral perfusion and depression on cognitive function in older adults with heart failure. Psychosom Med [Internet]. 2013 [cited 2017 Aug 21];75(7):632–9. Available from:
  81. 81.
    Alosco ML, Hayes SM. Structural brain alterations in heart failure: a review of the literature and implications for risk of Alzheimer’s disease. Heart Fail Rev [Internet]. 2015 [cited 2017 Aug 21];20(5):561–71. Available from:
  82. 82.
    Alosco ML, Spitznagel MB, Cohen R, Raz N, Sweet LH, Josephson R, et al. Reduced cerebral perfusion predicts greater depressive symptoms and cognitive dysfunction at a 1-year follow-up in patients with heart failure. Int J Geriatr Psychiatry [Internet]. 2014 [cited 2017 Aug 21];29(4):428–36. Available from:
  83. 83.
    Easton K, Coventry P, Lovell K, Carter L, Deaton C. Prevalence and measurement of anxiety in samples of patients with heart failure. J Cardiovasc Nurs [Internet]. 2015 [cited 2017 Aug 21];7(4):7. Available from:
  84. 84.
    Andreescu C, Varon D. New research on anxiety disorders in the elderly and an update on evidence-based treatments. Curr Psychiatry Rep [Internet]. 2015 [cited 2017 Aug 21];17(7):53. Available from:
  85. 85.
    Schiffer AA, Pedersen SS, Broers H, Widdershoven JW, Denollet J. Type-D personality but not depression predicts severity of anxiety in heart failure patients at 1-year follow-up. J Affect Disord. 2008;106(1–2):73–81.CrossRefGoogle Scholar
  86. 86.
    van Gestel YRBM, Pedersen SS, van de Sande M, de Jaegere PPT, Serruys PW, Erdman RAM, et al. Type-D personality and depressive symptoms predict anxiety 12 months post-percutaneous coronary intervention. J Affect Disord [Internet]. 2007 [cited 2017 Aug 21];103(1–3):197–203. Available from:
  87. 87.
    MacMahon KMA, Lip GYH. Psychological factors in heart failure: a review of the literature. Arch Intern Med [Internet]. 2002 [cited 2017 Aug 21];162(5):509–16. Available from:
  88. 88.
    Larsen KK, Christensen B, Søndergaard J, Vestergaard M. Depressive symptoms and risk of new cardiovascular events or death in patients with myocardial infarction: a population-based longitudinal study examining health behaviors and health care interventions. Moretti C, editor. PLoS One [Internet]. 2013 [cited 2017 Aug 19];8(9):e74393. Available from:
  89. 89.
    Joëls M, Baram TZ. The neuro-symphony of stress. Nat Rev Neurosci [Internet]. 2009 [cited 2017 Aug 21];10(6):459. Available from:
  90. 90.
    Szczepanska-Sadowska E, Cudnoch-Jedrzejewska A, Ufnal M, Zera T. Brain and cardiovascular diseases: common neurolgenic background of cardiovascular, metabolic and inflammatory diseases. J Physiol Pharmacol. 2010;61(5):509–21.PubMedGoogle Scholar
  91. 91.
    McDevitt-Petrovic O, Kirby K, Shevlin M. The prevalence of non-cardiac chest pain (NCCP) using emergency department (ED) data: a Northern Ireland based study. BMC Health Serv Res [Internet]. 2017 [cited 2017 Aug 19];17(1):549. Available from:
  92. 92.
    Bruno RR, Donner-Banzhoff N, Söllner W, Frieling T, Müller C, Christ M. Interdisziplinäre Versorgung akuter Thoraxschmerzen [Internet]. Deutsches Arzteblatt Int. 2015 [cited 2017 Aug 19];112:768–80. Available from:
  93. 93.
    Huffman JC, Pollack MH, Stern TA. Panic disorder and chest pain: mechanisms, morbidity, and management. Prim Care Companion J Clin Psychiatry [Internet]. 2002 [cited 2017 Aug 19];4(2):54–62. Available from:
  94. 94.
    Van Bergen P, Secondary CA, Author C, De Lange T, Tijssen R, Damman P, et al. Clinical characteristics of patients with suspected cardiac chest pain, and angiographic normal coronary arteries in a secondary care hospital. Neth Heart J. 2013;25(6):370–5.Google Scholar
  95. 95.
    Campbell KA, Madva EN, Villegas AC, Beale EE, Beach SR, Wasfy JH, et al. Non-cardiac chest pain: a review for the consultation-liaison psychiatrist. Psychosomatics. 2017;58(3):252–65.CrossRefGoogle Scholar
  96. 96.
    Kritek PA, Choi AMK. Disorders of the respiratory system. In: Kasper DL, Fauci AS, Hauser SL, Longo DL, Jameson JL, Loscalzo J, editors. Harrison’s principles of internal medicine. 19th ed. New York: McGraw-Hill; 2015. p. 1661–2.Google Scholar
  97. 97.
    WHO. World Health Organization. Global surveillance, prevention and control of chronic respiratory diseases: a comprehensive approach. Geneva, Switzerland. ISBN 978 92 4 156346 8. [Internet]. 2007 [cited 2017 Sep 3];2007:1–146. Available from:
  98. 98.
    Boulet L, Fitzgerald JM, Reddel HK. The revised 2014 Gina strategy report: opportunities for change. Curr Opin Pulm Med [Internet]. 2015 [cited 2017 Sep 3];21(1):1–7. Available from:
  99. 99.
    Chesnutt A, Chesnutt M, Prendergast TJ. Pulmonary disorders. In: Papadakis M, McPhee S, Rabow M, editors. Current medical diagnosis & treatment 2018. 57th ed. New York: McGraw-Hill; 2018.Google Scholar
  100. 100.
    Jain A, Lolak S. Psychiatric aspects of chronic lung disease. Curr Psychiatry Rep [Internet]. 2009 [cited 2017 Sep 3];11(3):219–25. Available from:
  101. 101.
    Asmundson GJ, Stein MB. Triggering the false suffocation alarm in panic disorder patients by using a voluntary breath-holding procedure. Am J Psychiatry [Internet]. 1994 [cited 2017 Sep 3];151(2):264–6. Available from:
  102. 102.
    Freire RC, Perna G, Nardi AE. Panic disorder respiratory subtype: psychopathology, laboratory challenge tests, and response to treatment. Harv Rev Psychiatry [Internet]. 2010 [cited 2017 Sep 3];18(4):220–9. Available from:
  103. 103.
    Niccolai V, van Duinen MA, Griez EJ. Respiratory patterns in panic disorder reviewed: a focus on biological challenge tests. Acta Psychiatr Scand [Internet]. 2009 [cited 2017 Sep 3];120(3):167–77. Available from:
  104. 104.
    von Leupoldt A, Kenn K. The psychology of chronic obstructive pulmonary disease. Curr Opin Psychiatry [Internet]. 2013;26(5):458–63. Available from:
  105. 105.
    Grohé C. Sex and gender differences in pulmonary disease. In: Oertelt-Prigione S, Regitz-Zagrosek V, editors. Sex and gender aspects in clinical medicine. London: Springer; 2012. p. 45–64.CrossRefGoogle Scholar
  106. 106.
    Yohannes AM, Willgoss TG, Baldwin RC, Connolly MJ. Depression and anxiety in chronic heart failure and chronic obstructive pulmonary disease: prevalence, relevance, clinical implications and management principles. Int J Geriatr Psychiatry [Internet]. 2010 [cited 2017 Aug 20];25(12):1209–21. Available from:
  107. 107.
    Papaioannou AI, Bartziokas K, Tsikrika S, Karakontaki F, Kastanakis E, Banya W, et al. The impact of depressive symptoms on recovery and outcome of hospitalised COPD exacerbations. Eur Respir J. 2013;41(4):815–23.CrossRefGoogle Scholar
  108. 108.
    Dalal AA, Shah M, Lunacsek O, Hanania NA. Clinical and economic burden of depression/anxiety in chronic obstructive pulmonary disease patients within a managed care population. COPD. 2011;8(4):293–9.CrossRefGoogle Scholar
  109. 109.
    Coventry PA, Bower P, Keyworth C, Kenning C, Knopp J, Garrett C, et al. The effect of complex interventions on depression and anxiety in chronic obstructive pulmonary disease: systematic review and meta-analysis. PLoS One. 2013;8(4):e60532.CrossRefPubMedPubMedCentralGoogle Scholar
  110. 110.
    Vozoris NT, Fischer HD, Wang X, Anderson GM, Bell CM, Gershon AS, et al. Benzodiazepine use among older adults with chronic obstructive pulmonary disease: a population-based cohort study. Drugs Aging [Internet]. 2013;30(3):183–92. Available from:
  111. 111.
    Tierney L, McPhee S, Papadakis M. Current medical diagnosis and treatment. New York: McGraw Hill Education; 2017. p. 1124.Google Scholar
  112. 112.
    Chawla LS, Eggers PW, Star RA, Kimmel PL. Acute kidney injury and chronic kidney disease as interconnected syndromes. N Engl J Med [Internet]. 2014;371(1):58–66. Available from:
  113. 113.
    Ricci Z, Cruz D, Ronco C. The RIFLE criteria and mortality in acute kidney injury: a systematic review. Kidney Int [Internet]. 2008;73(5):538–46. Available from:
  114. 114.
    Bellomo R, Kellum JA, Ronco C. Acute kidney injury. Lancet. 2012;380:756–66.Google Scholar
  115. 115.
    Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl [Internet]. 2012;2(1):1–138. Available from:
  116. 116.
    Susantitaphong P, Cruz DN, Cerda J, Abulfaraj M, Alqahtani F, Koulouridis I, et al. World incidence of AKI: A meta-analysis. Clin J Am Soc Nephrol. 2013;8(9):1482–93.CrossRefPubMedPubMedCentralGoogle Scholar
  117. 117.
    Rewa O, Bagshaw SM. Acute kidney injury-epidemiology, outcomes and economics. Nat Rev Nephrol [Internet]. 2014;10(4):193–207. Available from:
  118. 118.
    Kellum JA, Unruh ML, Murugan R. Acute kidney injury. BMJ Clin Evid [Internet]. 2011;2011(December 2009):1–36. Available from:
  119. 119.
    American Psychiatric Association. Diagnostic and statistical manual of mental disorders [Internet]. Arlington; 2013. 991 p. Available from:,2__Orightresult__X3;jsessionid=ABB7428ECBC4BA66625EDD0E0C5AAFA5?lang=eng&suite=cobalt%5Cn;
  120. 120.
    Sciani G, Ferreira KG, Streck EL. Mechanisms underlying uremic encephalopathy. Rev Bras Ter Intensiva. 2010;22(2):206–11.CrossRefGoogle Scholar
  121. 121.
    Levin A, Stevens PE, Bilous RW, Coresh J, De Francisco ALM, De Jong PE, et al. Kidney disease: improving global outcomes (KDIGO) CKD work group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl [Internet]. 2013;3(1):1–150. Available from:
  122. 122.
    Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B, et al. Chronic kidney disease: global dimension and perspectives. Lancet. 2013;382(9888):260–72.CrossRefGoogle Scholar
  123. 123.
    Feehally J, Harrington JT, Bello AK, Gorovich A, Pierides A, Pusey C, et al. Ethnicity and renal disease. Kidney Int. 2005;68:414–24.Google Scholar
  124. 124.
    Nugent RA, Fathima SF, Feigl AB, Chyung D. The burden of chronic kidney disease on developing nations: a 21st century challenge in global health. Nephron Clin Pract. 2011;118:c269–77.Google Scholar
  125. 125.
    Palmer S, Vecchio M, Craig JC, Tonelli M, Johnson DW, Nicolucci A, et al. Prevalence of depression in chronic kidney disease: systematic review and meta-analysis of observational studies. Kidney Int [Internet]. 2013;84(1):179–91. Available from:
  126. 126.
    Bautovich A, Katz I, Smith M, Loo CK, Harvey SB. Depression and chronic kidney disease: a review for clinicians. Aust N Z J Psychiatry [Internet]. 2014;48(6):530–41. Available from:
  127. 127.
    Susan Hedayati S, Yalamanchili V, Finkelstein FO. A practical approach to the treatment of depression in patients with chronic kidney disease and end-stage renal disease. Kidney Int [Internet]. 2012;81(3):247–55. Available from:
  128. 128.
    Shirazian S, Grant CD, Aina O, Mattana J, Khorassani F. Depression in chronic kidney disease and end-stage renal disease: similarities and differences in diagnosis, epidemiology, and management. Kidney Int Rep. 2017;2:94–107.Google Scholar
  129. 129.
    Trenkwalder C, Paulus W. Restless legs syndrome: pathophysiology, clinical presentation and management. Nat Rev Neurol [Internet]. 2010;6(6):337–46. Available from:
  130. 130.
    Trenkwalder C, Allen R, Högl B, Paulus W, Winkelmann J. Restless legs syndrome associated with major diseases. Neurology. 2016;86:1336–43.Google Scholar
  131. 131.
  132. 132.
    Azab AN, Shnaider A, Osher Y, Wang D, Bersudsky Y, Belmaker RH. Lithium nephrotoxicity. Int J bipolar Disord [Internet]. 2015;3(1):28. Available from:
  133. 133.
    De Oliveira JL, Da Silva Júnior GB, De Abreu KLS, Rocha NDA, Franco LFLG, Araújo SMHA, et al. Lithium nephrotoxicity. Rev Assoc Med Bras [Internet]. 2010;56(5):600–6. Available from:
  134. 134.
    Gitlin M. Lithium side effects and toxicity: prevalence and management strategies. Int J Bipolar Disord [Internet]. 2016;4(1):27. Available from:
  135. 135.
    Lepkifker E, Sverdlik A, Iancu I, Ziv R, Segev S, Kotler M. Renal insufficiency in long-term lithium treatment. J Clin Psychiatry. 2004;65(6):850–6.CrossRefGoogle Scholar
  136. 136.
    Grünfeld J-P, Rossier BC. Lithium nephrotoxicity revisited. Nat Rev Nephrol [Internet]. 2009;5(5):270–6. Available from:
  137. 137.
    Gazoni F, Vendrame L, Nacif S, Lopes R, Lopes A. Doenças clínicas que afetam a saúde mental da mulher. In: Joel Rennó Junior HLR, editor. Tratado de Saúde Mental da Mulher. 1st ed. São Paulo: Atheneu; 2012. p. 31–43.Google Scholar
  138. 138.
    Rivelli SK, Shirey KG. Prevalence of psychiatric symptoms/syndromes in medical settings. In: Integrated care in psychiatry. New York: Springer New York; 2014. p. 5–27.CrossRefGoogle Scholar
  139. 139.
    Rundell J. Medical conditions associated with psychiatric disorders. In: Gelder MG, Andreasen N, López-Ibor Jr JJ, Geddes JR, editors. New Oxford textbook of psychiatry. 2nd ed. Oxford: Oxford University Press; 2009. p. 1081–90.Google Scholar
  140. 140.
    Annamalai A. Medical management of psychotropic side effects. New York: Springer; 2017. p. 93–102.CrossRefGoogle Scholar
  141. 141.
    Williams K, Rasgon N. Psychosomatic medicine: endocrine and metabolic disorders. In: Sadock BJ, Sadock VA, Ruiz P, editors. Kaplan & Sadock’s comprehensive textbook of psychiatry. 10th ed. Philadelphia: Lippincott; 2017.Google Scholar
  142. 142.
    Verma R, Balhara YPS, Gupta CS. Gender differences in stress response: role of developmental and biological determinants. Ind Psychiatry J. 2011;20(1):4–10.PubMedPubMedCentralGoogle Scholar
  143. 143.
    Dunaif A. Women’s health. In: Kasper DL, Hauser SL, Jameson J, Fauci A, Longo DL, Loscalzo J, editors. Harrisson’s principles of internal medicine. 19th ed. New York: McGraw Hill Education; 2015. p. 45.Google Scholar
  144. 144.
    Ashton K, Lavery M. Psychosomatic medicine: obesity. In: Sadock BJ, Sadock VA, Ruiz P, editors. Kaplan & Sadock’s comprehensive textbook of psychiatry. 10th ed. Philadelphia: Lippincott; 2017.Google Scholar
  145. 145.
    Nejad SH, Roffman JL, Kueppenbender K, Smith FA, Huffman J, Stern TA. Patients with neurologic conditions II. In: Stern TA, Fricchione GL, Cassem NH, Jellinek MS, Rosenbaum JF, editors. Massachusetts General Hospital handbook of general hospital psychiatry. 6th ed. Philadelphia: Saunders Elsevier; 2010. p. 255–72.CrossRefGoogle Scholar
  146. 146.
    Rivelli SK, Shirey KG. Prevalence of psychiatric symptoms/syndromes in medical settings. In: Integrated care in psychiatry [Internet]. New York: Springer New York; 2014. p. 5–27. Available from: Scholar
  147. 147.
    Ayuso-Mateos JL. Psychiatric aspects of infections. In: Gelder M, et al., editors. New Oxford textbook of psychiatry. Oxford: Oxford University Press; 2009. p. 1090–5.Google Scholar
  148. 148.
    Lukehart SA. Syphilis. In: Harrison’s principles of internal medicine. New York: McGraw Hill Education; 2015. p. 1132–40.Google Scholar
  149. 149.
    Munjal S, Ferrando SJ, Freyberg Z. Neuropsychiatric aspects of Infectious diseases: an update. Crit Care Clin. 2017;33(3):681–712.CrossRefPubMedPubMedCentralGoogle Scholar
  150. 150.
    Britton PN, Eastwood K, Paterson B, Durrheim DN, Dale RC, Cheng AC, et al. Consensus guidelines for the investigation and management of encephalitis in adults and children in Australia and New Zealand. Intern Med J. 2015;45(5):563–76.CrossRefGoogle Scholar
  151. 151.
    Schneider RK, Robinson MJ, Levenson JL. Psychiatric presentations of non-HIV infectious diseases. Pediatr Autoimmun Neuropsychiatr Infect. 2002;25(1):1–16.Google Scholar
  152. 152.
    Fleury A, Dessein A, Preux PM, Dumas M, Tapia G, Larralde C, et al. Symptomatic human neurocysticercosis--age, sex and exposure factors relating with disease heterogeneity. J Neurol. 2004;251(7):830–7.CrossRefGoogle Scholar
  153. 153.
    Koo J. Psychodermatology: diagnosis and practical management. Saudi Med J. 1998;19:653–6.Google Scholar
  154. 154.
    Gupta AK, Jafferany M. Psychocutaneous disorders. In: Kaplan & Sadock’s comprehensive textbook of psychiatry. 10th ed. Philadelphia: Lippincott; 2017.Google Scholar
  155. 155.
    Connor CJ. Management of the psychological comorbidities of dermatological conditions: practitioners’ guidelines. Clin Cosmet Investig Dermatol. 2017;10:117–32.Google Scholar
  156. 156.
    Botha CA, Ruffle JK, Farmer AD. Gastrointestinal disorders. In: Sadock BJ, Sadock VA, Ruiz P, editors. Kaplan & Sadock’s comprehensive textbook of psychiatry two volumes. 10th ed. Philadelphia, Baltimore, New York, London, Buenos Aires, Hong Kong, Sydney, Tokyo: Wolters Kluwer; 2017. p. 5619–44.Google Scholar
  157. 157.
    Bharadwaj S, Barber MD, Graff LA, Shen B. Symptomatology of irritable bowel syndrome and inflammatory bowel disease during the menstrual cycle. Gastroenterol Rep [Internet]. 2015;3(3):185–93. Available from:
  158. 158.
    Rosenblatt E, Kane S. Sex-specific issues in inflammatory bowel disease. Gastroenterol Hepatol. 2015;11:592–601.Google Scholar
  159. 159.
    Nee J, Feuerstein JD. Optimizing the care and health of women with inflammatory bowel disease. Gastroenterol Res Pract. 2015;2015:1–8.Google Scholar
  160. 160.
    Neuendorf R, Harding A, Stello N, Hanes D, Wahbeh H. Depression and anxiety in patients with Inflammatory Bowel disease: a systematic review. J Psychosom Res. 2016;87:70–80.Google Scholar
  161. 161.
    Mikocka-Walus A, Knowles SR, Keefer L, Graff L. Controversies revisited: a systematic review of the comorbidity of depression and anxiety with inflammatory Bowel diseases. Inflamm Bowel Dis [Internet]. 2016;22(3):752–62. Available from:
  162. 162.
    Tevfik Dorak M, Karpuzoglu E. Gender differences in cancer susceptibility: an inadequately addressed issue. Front Genet. 2012;3(Nov):1–11.Google Scholar
  163. 163.
    Cook MB, Dawsey SM, Freedman ND, Inskip PD, Wichner SM, Quraishi SM, et al. Sex disparities in cancer incidence by period and age. Cancer Epidemiol Biomark Prev. 2009;18(4):1174–82.CrossRefGoogle Scholar
  164. 164.
    Longo DL. Approach to the patient with cancer. In: Fauci KD, Hauser S, Longo D, Jameson J, Loscalzo J, editors. Harrison’s principles of internal medicine. New York: McGraw-Hill Education; 2017. p. 467–75.Google Scholar
  165. 165.
    Fingeret MC, Teo I, Epner DE. Managing body image difficulties of adult cancer patients: lessons from available research. Cancer. 2014;120:633–41.Google Scholar
  166. 166.
    Syrowatka A, Motulsky A, Kurteva S, Hanley J, Dixon W, Meguerditchian A, et al. Predictors of distress in female breast cancer survivors: a systematic review. Breast Cancer Res Treat [Internet]. 2017;165(2):229–45. Available from:
  167. 167.
    Heffernan SP, Alici Y, Breitbart WS, Lederberg MS. Psycho-oncology. In: Kaplan & Sadock’s comprehensive textbook of psychiatry. Philadelphia: Lippincott; 2017.Google Scholar
  168. 168.
    Ron MA. Psychiatric aspects of neurological disease. In: Gelder MG, Andreasen N, López-Ibor Jr JJ, Geddes JR, editors. New Oxford textbook of psychiatry. 2nd ed. Oxford: Oxford University Press; 2009. p. 1071–5.Google Scholar
  169. 169.
    Booth J, Connelly L, Lawrence M, Chalmers C, Joice S, Becker C, et al. Evidence of perceived psychosocial stress as a risk factor for stroke in adults: a meta-analysis. BMC Neurol [Internet]. 2015;15:233. Available from:
  170. 170.
    Hackett ML, Anderson CS. Predictors of depression after stroke: a systematic review of observational studies. Stroke. 2005;36(10):2296–301.CrossRefGoogle Scholar
  171. 171.
    House A, Dennis M, Mogridge L, Warlow C, Hawton K, Jones L. Mood disorders in the year after first stroke. Br J Psychiatry [Internet]. 1991;158:83–92. Available from:
  172. 172.
    Huffman JC, Brennan MM, Smith FA, Stern TA. Patients with neurologic conditions I. In: Stern TA, Fricchione GL, Cassem NH, Jellinek MS, Rosenbaum JF, editors. Massachusetts General Hospital handbook of general hospital psychiatry. 6th ed. Philadelphia: Saunders Elsevier; 2010. p. 237–54.CrossRefGoogle Scholar
  173. 173.
    Munivenkatappa A, Agrawal A, Shukla DP, Kumaraswamy D, Devi BI. Traumatic brain injury: does gender influence outcomes? Int J Crit Illn Inj Sci. 2016;6(2):70–3.CrossRefPubMedPubMedCentralGoogle Scholar
  174. 174.
    Rogers JM, Read CA. Psychiatric comorbidity following traumatic brain injury. Brain Inj. 2007;21(December):13–4.Google Scholar
  175. 175.
    Toone B. Epilepsy. In: Gelder MG, Andreasen N, López-Ibor Jr JJ, Geddes JR, editors. New Oxford textbook of psychiatry. 2nd ed. Oxford: Oxford University Press; 2009. p. 1076–81.Google Scholar
  176. 176.
    Luef G, Taubøll E. Gender issues in epilepsy – difference in management of epilepsy. Seizure. 2015;28:1–2.CrossRefGoogle Scholar
  177. 177.
    Taubøll E, Sveberg L, Svalheim S. Interactions between hormones and epilepsy. Seizure. 2015;28:3–11.CrossRefGoogle Scholar
  178. 178.
    Kanner AM. Management of psychiatric and neurological comorbidities in epilepsy. Nat Rev Neurol. 2016;12(2):106–16.CrossRefGoogle Scholar
  179. 179.
    Kanner AM. Psychiatric comorbidities in epilepsy: should they be considered in the classification of epileptic disorders? Epilepsy Behav. 2016;64:306–8.CrossRefGoogle Scholar
  180. 180.
    Lowenstein DH. Seizures and epilepsy. In: Kasper DL, Hauser SL, Jameson J, Fauci A, Longo DL, Loscalzo J, editors. Harrisson’s principles of internal medicine. 19th ed. New York: McGraw Hill Education; 2015. p. 2542.Google Scholar
  181. 181.
    LaFrance WC, Kanner AM, Hermann B. Psychiatric comorbidities in epilepsy. Int Rev Neurobiol. 2008;83(8):347–83.CrossRefGoogle Scholar
  182. 182.
    Emre M. Dementia associated with Parkinson’s disease. Lancet Neurol. 2003;2(4):229–37.CrossRefGoogle Scholar
  183. 183.
    Miller IN, Cronin‐Golomb A. Gender differences in Parkinson’s disease: clinical characteristics and cognition. Mov Disord. 2011;25(16):2695–703.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  • Sarah Rückl
    • 1
  • Tiago Couto
    • 2
  • Juliana Parada
    • 3
  • Carlos Eduardo Rosa
    • 4
    Email author
  1. 1.Department of Mental HealthFederal University of Minas GeraisBelo HorizonteBrazil
  2. 2.Federal University of UberlandiaUberlandiaBrazil
  3. 3.Independent ScholarBelo HorizonteBrazil
  4. 4.Division of Psychiatric, Neuroscience and Behavior Department, and Division of Radiology, Internal Medicine DepartmentHospital of Clinics, Ribeirão Preto Medical School, University of São PauloRibeirão PretoBrazil

Personalised recommendations